PT3 is a selective inhibitor of HDAC3 with an IC50 value of 0.25 µM. It demonstrates good brain penetration and bioavailability when administered orally. PT3 is applicable for research in Alzheimers disease.
Molecular Weight:
319.36
CAS Number:
[2710273-81-5]
Formula:
C18H17N5O
Target:
HDAC
T207551
* VAT and and shipping costs not included. Errors and price changes excepted